Bluejay Diagnostics (BJDX) Other financing activities (2021 - 2026)
Bluejay Diagnostics (BJDX) reported Other financing activities of $1051.0 for Q1 2026, up 6.7% on a YoY basis from $985.0 in Q1 2025, and up 1.74% sequentially from $1033.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Other financing activities (2021 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 5 years of Other financing activities data on file, last reported at $1051.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 6.7% year-over-year to $1051.0; the trailing twelve-month figure through Mar 2026 stood at $4093.0 (up 7.01% YoY), and the FY2025 full-year result was $4027.0, up 7.27% from the prior year.
- Other financing activities grew to $1051.0 in Q1 2026, from $1033.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $3228.0 in Q4 2024 to a low of -$1318.0 in Q3 2024.
- A 4-year average of $1049.2 and a median of $1033.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities slumped 209.65% in 2024 and jumped 177.01% in 2025, its largest moves.
- Tracing BJDX's Other financing activities over 4 years: stood at $1202.0 in 2023, then soared by 168.55% to $3228.0 in 2024, then tumbled by 68.0% to $1033.0 in 2025, then climbed by 1.74% to $1051.0 in 2026.
- Business Quant data shows BJDX's Other financing activities at $1051.0 in Q1 2026, $1033.0 in Q4 2025, and $1015.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,051.00 |
| Mar 31, 2026 | 1,051.00 |
| Dec 31, 2025 | 1,033.00 |
| Dec 31, 2025 | 1,033.00 |
| Sep 30, 2025 | 1,015.00 |
| Sep 30, 2025 | 1,015.00 |
| Jun 30, 2025 | 994.00 |
| Jun 30, 2025 | 994.00 |
| Mar 31, 2025 | 985.00 |
| Mar 31, 2025 | 985.00 |
| Dec 31, 2024 | 3,228.00 |
| Dec 31, 2024 | 3,228.00 |
| Sep 30, 2024 | -1,318.00 |
| Sep 30, 2024 | -1,318.00 |
| Jun 30, 2024 | 930.00 |
| Jun 30, 2024 | 930.00 |
| Mar 31, 2024 | 914.00 |
| Mar 31, 2024 | 914.00 |
| Dec 31, 2023 | 1,202.00 |
| Dec 31, 2023 | 1,202.00 |